We would like to thank everyone that participated in the live streaming session. This recorded session is now available for viewing in our site archive. If you would like to purchase this recording for viewing, you are welcome to visit our here. Once purchased, you may return to this page and login.
Initially, the access was 15 days. Dr. Anderson suggested extending this access to 60 days. As always, his goal is to foster an educational culture that supports your ability to get the information you need. He felt allowing longer access helps you and supports this vision.
Please contact our web support team. Our team will respond as quickly as possible.
For all these questions and more, the answer is “it depends…”
The FDA has cracked down on compounded injectable solutions for in-office use after an outbreak of fungal meningitis was attributed to a contaminated compounded product that killed 55 people and sickened 700 nationally. FDA regulations have been an ever moving and baffling target, largely resulting in providers needing to order compounded injectables in individual doses for specific patients only, thereby increasing costs, delaying timely treatment, and creating barriers to patient care.
Dr. Paul Anderson has spent the last two years sorting through official documents, consulting with industry experts including pharmacy and legal professionals, and conducting personal investigations for private medical practices impacted by the FDA rules. In this course, Dr. A consolidates the laws and rules you need to observe, will walk you through best clinical practices for enhanced patient safety, and will answer all your questions about how to legally use injectable compounded medications in your practice.
This is a MUST TAKE seminar for anyone who does IVs.
OANP Webinar ArchiveVisit Shop Now
Please Login Here